EFFECTS OF MAXIMALLY TOLERATED ORAL-THERAPY ON THE 6-MINUTE WALKING TEST IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO EITHER ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY

Citation
A. Gualeni et al., EFFECTS OF MAXIMALLY TOLERATED ORAL-THERAPY ON THE 6-MINUTE WALKING TEST IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO EITHER ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY, The American journal of cardiology, 81(11), 1998, pp. 1370
Citations number
13
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
81
Issue
11
Year of publication
1998
Database
ISI
SICI code
0002-9149(1998)81:11<1370:EOMTOO>2.0.ZU;2-7
Abstract
In patients with heart failure, therapy with ''maximally tolerated'' o ral doses of diuretics, vasodilators, and digitalis results in a signi ficant increase in the distance walked during the B-minute walking tes t, compared with conventional therapy at ''standard'' doses, indicatin g an improvement in exercise tolerance. The 6-minute walk test is a si mple, inexpensive, and well-tolerated test to measure changes in exerc ise tolerance induced by pharmacologic interventions, even on a short- term basis.